Benefits of Weight Loss for the Heart Reduced strain on the heart muscle Lower systolic and diastolic blood pressure Improved cholesterol profiles (increased HDL, decreased LDL and triglycerides) Reduced risk of heart disease and stroke How GLP-1 Medications Support More Than Weight Loss GLP-1 receptor agonists such as semaglutide and tirzepatide were originally developed to support blood sugar control
Our philosophy is built on partnership, safety, and genuine support
More information at: Wegovy is a registered trademark of Novo Nordisk A/S
We need to take the long view and think more strategically and realistically about the crucial role of these medications in contributing to the health and well-being of Rhode Islanders
Digestive acids and enzymes can break down peptides before theyre absorbed
In the SUSTAIN6 trial, semaglutide (a GLP-1RA) significantly increased diabetic retinopathy complications, including vitreous hemorrhage [2], while a recent retrospective cohort study of patients with type 2 diabetes showed that use of GLP-1RAs modestly increased the incident risk of diabetic retinopathy, although sight-threatening diabetic complications including blindness were somewhat lower in patients treated with GLP-1 RAs [5]
